Hypoxia-inducible factor-1α polymorphisms and TSC1/2 mutations are complementary in head and neck cancers
2006

HIF-1α Polymorphisms and TSC1/2 Mutations in Head and Neck Cancers

Sample size: 28 publication 10 minutes Evidence: moderate

Author Information

Author(s): Hebert Carla, Norris Kathleen, Parashar Pallavi, Ord Robert A, Nikitakis Nikolaos G, Sauk John J

Primary Institution: University of Maryland Baltimore

Hypothesis

Dysregulation of TSC1/TSC2 may complement HIF-1α expression in head and neck cancers.

Conclusion

Mutations in the TSC1/TSC2 complex complement HIF-1α polymorphisms in head and neck squamous cell carcinoma, potentially serving as biomarkers for therapy response and prognosis.

Supporting Evidence

  • 6 out of 28 patients showed mismatched heteroduplex patterns indicating genetic changes.
  • 5 of the 6 cases with changes were identified as polymorphisms.
  • High levels of HIF-1α were found in tumors with HIF-1α polymorphisms or mutations.

Takeaway

This study looked at changes in certain genes in patients with throat cancer and found that these changes can affect how a protein related to cancer behaves.

Methodology

The study involved analyzing DNA from 28 patients with oral squamous cell carcinoma for polymorphisms in HIF-1α and mutations in TSC1/TSC2 using DHPLC and sequencing.

Limitations

The study was limited to a small sample size and focused only on specific genetic changes.

Participant Demographics

16 males and 12 females with oral squamous cell carcinoma.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1476-4598-5-3

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication